Guideline-conform statin use reduces overall mortality in patients with compensated liver disease

Statins reduce cardiovascular risk. However, “real-life” data on statin use in patients with chronic liver disease and its impact on overall and liver-related survival are limited. Therefore, we assessed 1265 CLD patients stratified as advanced (ACLD) or non-advanced (non-ACLD) stage. Statin indicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Unger, Lukas W., Forstner, Bernadette, Schneglberger, Stephan, Muckenhuber, Moritz, Eigenbauer, Ernst, Bauer, David, Scheiner, Bernhard, Mandorfer, Mattias, Trauner, Michael, Reiberger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690990/
https://www.ncbi.nlm.nih.gov/pubmed/31406146
http://dx.doi.org/10.1038/s41598-019-47943-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690990/
https://www.ncbi.nlm.nih.gov/pubmed/31406146
http://dx.doi.org/10.1038/s41598-019-47943-6

Ejemplares similares